Business
– Mesupron, which targets gastrointestinal and other cancers, has been licensed from Wilex. RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has expanded its late clinical-stage gastrointestinal-focused pipeline...
Hi, what are you looking for?
– Mesupron, which targets gastrointestinal and other cancers, has been licensed from Wilex. RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has expanded its late clinical-stage gastrointestinal-focused pipeline...
– Invention seen as having huge commercial potential – – Eating fruits and vegetables is good for you, but sometimes there’s a price...
– The Chinese company will invest $4 million in CollPlant in exchange for an allotment of shares and the commercialization of its products in...